Overview

A Study of RX-10045 in the Treatment of Dry Eye Disease

Status:
Completed

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to assess the efficacy, tolerability and safety of RX-10045 Ophthalmic Solution in patients with Dry Eye Disease.

Phase:

Phase 2

Details

Lead Sponsor:

C.T. Development America, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions